Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain
about
Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discoveryPathogen recognition and activation of the innate immune response in zebrafishCD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimerApolipoprotein B Is an innate barrier against invasive Staphylococcus aureus infectionCD36: implications in cardiovascular diseaseA CD36 ectodomain mediates insect pheromone detection via a putative tunnelling mechanismSplenic Macrophage Subsets and Their Function during Blood-Borne InfectionsCo-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signalingNonprofessional phagocytic cell receptors involved in Staphylococcus aureus internalizationLeishmania amazonensis Engages CD36 to Drive Parasitophorous Vacuole MaturationDrosophila embryos as model systems for monitoring bacterial infection in real timeSteroid hormone signaling is essential to regulate innate immune cells and fight bacterial infection in DrosophilaCD9 tetraspanin interacts with CD36 on the surface of macrophages: a possible regulatory influence on uptake of oxidized low density lipoproteinCD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammationCD36 is a novel serum amyloid A (SAA) receptor mediating SAA binding and SAA-induced signaling in human and rodent cellsTLR2 mediates recognition of live Staphylococcus epidermidis and clearance of bacteremiaApoptotic cell recognition receptors and scavenger receptors.Toll-like receptor 2 (TLR2)-TLR9 crosstalk dictates IL-12 family cytokine production in microglia.CD36-specific antibodies block release of HIV-1 from infected primary macrophages and its transmission to T cells.S. aureus blocks efferocytosis of neutrophils by macrophages through the activity of its virulence factor alpha toxin.CD36 deficiency impairs the small intestinal barrier and induces subclinical inflammation in mice.A potential new pathway for Staphylococcus aureus dissemination: the silent survival of S. aureus phagocytosed by human monocyte-derived macrophages.Soluble CD36 ectodomain binds negatively charged diacylglycerol ligands and acts as a co-receptor for TLR2.Human SR-BII mediates SAA uptake and contributes to SAA pro-inflammatory signaling in vitro and in vivoInhibition of CD36-dependent phagocytosis by prostaglandin E2 contributes to the development of endometriosis4,4'-Diaponeurosporene-Producing Bacillus subtilis Increased Mouse Resistance against Salmonella typhimurium Infection in a CD36-Dependent MannerCD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior.Type 2 scavenger receptor CD36 in platelet activation: the role of hyperlipemia and oxidative stress.Tlr2 is critical for diet-induced metabolic syndrome in a murine model.Comparative genomic analysis of innate immunity reveals novel and conserved components in crustacean food crop species.CD36 deficiency attenuates experimental mycobacterial infection.CD36 and TLR interactions in inflammation and phagocytosis: implications for malaria.Relative roles of the cellular and humoral responses in the Drosophila host defense against three gram-positive bacterial infections.Transcriptomic analysis of milk somatic cells in mastitis resistant and susceptible sheep upon challenge with Staphylococcus epidermidis and Staphylococcus aureusClass B scavenger receptor types I and II and CD36 mediate bacterial recognition and proinflammatory signaling induced by Escherichia coli, lipopolysaccharide, and cytosolic chaperonin 60An insect multiligand recognition protein functions as an opsonin for the phagocytosis of microorganismsAnopheles gambiae Croquemort SCRBQ2, expression profile in the mosquito and its potential interaction with the malaria parasite Plasmodium bergheiPhagocytosis and phagosome acidification are required for pathogen processing and MyD88-dependent responses to Staphylococcus aureus.Drosophila phagocytosis - still many unknowns under the surface.Scavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular disease
P2860
Q21285000-7F9C29EB-5B1E-4A16-9CBF-D176C21652E6Q21296719-CA8A8ACB-6DB4-403C-9141-92C615D59D07Q24642646-5D96D8CF-A948-4C76-BADD-2D2741CB33FFQ24654997-6E4A486E-4FED-4D74-B434-9706C2C9388BQ24678338-D2B8E697-A8D9-41CD-B63C-1F39B899ACE4Q26314673-000A28B4-D376-445D-8FE8-51A5D00AD1A8Q26781264-2923395C-4B32-4B55-8B95-F3A075E46CB5Q26866939-F84BF901-F213-4D27-8734-E50832E3D3E1Q27022826-8F3423F7-EB4C-4E71-B315-8867B65B5C2EQ27313642-3B904544-0BEE-4118-81F3-FD5077C7476EQ27316528-A6F00E4E-2906-4B5E-A977-D81D81ACBD52Q27332102-2C4D40B1-1B78-479A-A4CF-5185CD36F7CDQ28478525-0734BC65-D6CD-4928-89FD-D78F352AEBBCQ28506984-897431A4-5986-4DF5-BDE5-E775E218583DQ28580132-DCBDAB4D-6265-4817-AE5E-B56CF90341D7Q28752617-337ADBDA-57C1-49CF-9949-2D4D0E756EC9Q30277892-919218DC-9EAE-4B26-8FB8-21CF711149C0Q30423121-30254352-0B59-4E82-B426-DA66894FF900Q30557430-F4CD2254-07DD-492E-A202-4DBBDA084A9EQ30822546-F1266CC0-572D-4F68-B6BE-A493B7858C2DQ30834090-8FB910F6-B686-4509-AD3A-9C77E6FE7DDBQ33313866-F2909859-A813-48CC-8EAF-6449A3F7DC90Q33511748-A616AE13-50CB-4983-912C-620D58E466CDQ33579601-66CE9A03-51BA-47E0-B819-9D2159C88BC1Q33597181-0C572F36-009E-41AD-A1D7-262B0B759BB6Q33603250-540FD544-ED25-4660-BCBB-C0D47EA77756Q33609100-F77ED997-C642-41AA-A47A-ED8D2D8EA7E6Q33641499-C46E51C9-3185-425E-AFD5-043E9B0EF749Q33694600-FC876A70-96D9-4323-9AA0-8F8413E126CAQ33705848-66DCCD32-C04B-4899-BBEB-24BCD61EEACEQ33719919-5DD382DF-89A6-4DE8-920A-5000B6257968Q33786117-D9D6CD1B-8B69-4697-A8FF-78300DF87EF8Q33842010-74E491D6-F329-4781-AEF9-7FFC0721B22CQ33884104-C03C4961-BF00-4063-9D30-BAB7C7F542A4Q33903801-B057B0DB-4AA9-4EF5-AB7C-961581558E27Q34055729-533878B8-01ED-41DA-ADC3-440179932800Q34068112-2B7C1C5D-D96D-412C-852E-D82B2833D9F5Q34112627-3611EB5E-17DC-44FE-A5C1-88199ED30FF8Q34216272-2C8991E0-BC4B-47ED-8F21-C6900E53EFD8Q34218552-5B2645C3-C25C-4A2F-AC16-38289202D0B1
P2860
Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domain
description
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2005
@ast
im August 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2005/08/01)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd op 2005/08/01)
@nl
наукова стаття, опублікована в серпні 2005
@uk
مقالة علمية (نشرت في أغسطس 2005)
@ar
name
Response to Staphylococcus aur ...... OH-terminal cytoplasmic domain
@ast
Response to Staphylococcus aur ...... OH-terminal cytoplasmic domain
@en
Response to Staphylococcus aur ...... OH-terminal cytoplasmic domain
@nl
type
label
Response to Staphylococcus aur ...... OH-terminal cytoplasmic domain
@ast
Response to Staphylococcus aur ...... OH-terminal cytoplasmic domain
@en
Response to Staphylococcus aur ...... OH-terminal cytoplasmic domain
@nl
prefLabel
Response to Staphylococcus aur ...... OH-terminal cytoplasmic domain
@ast
Response to Staphylococcus aur ...... OH-terminal cytoplasmic domain
@en
Response to Staphylococcus aur ...... OH-terminal cytoplasmic domain
@nl
P2093
P2860
P3181
P356
P1476
Response to Staphylococcus aur ...... OH-terminal cytoplasmic domain
@en
P2093
Anita A. Tseng
Elizabeth J. Hennessy
Jessica M. Silver
Jiusheng Deng
Kathryn J. Moore
Kazue Takahashi
Lynda M. Stuart
R. Alan B. Ezekowitz
P2860
P304
P3181
P356
10.1083/JCB.200501113
P407
P577
2005-08-01T00:00:00Z